SELLAS Life Sciences (SLS) Other Gross PP&E Adjustments (2019 - 2024)

SELLAS Life Sciences (SLS) has disclosed Other Gross PP&E Adjustments for 8 consecutive years, with -$829000.0 as the latest value for Q3 2024.

  • On a quarterly basis, Other Gross PP&E Adjustments rose 7.48% to -$829000.0 in Q3 2024 year-over-year; TTM through Sep 2024 was -$829000.0, a 7.48% increase, with the full-year FY2023 number at -$1.3 million, down 7.34% from a year prior.
  • Other Gross PP&E Adjustments was -$829000.0 for Q3 2024 at SELLAS Life Sciences, down from -$756000.0 in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of -$257000.0 in Q1 2020 to a low of -$1.6 million in Q1 2023.
  • A 5-year average of -$1.1 million and a median of -$1.1 million in 2022 define the central range for Other Gross PP&E Adjustments.
  • Peak YoY movement for Other Gross PP&E Adjustments: surged 45.44% in 2020, then tumbled 347.47% in 2021.
  • SELLAS Life Sciences' Other Gross PP&E Adjustments stood at -$971000.0 in 2020, then grew by 11.12% to -$863000.0 in 2021, then crashed by 40.44% to -$1.2 million in 2022, then fell by 7.34% to -$1.3 million in 2023, then surged by 36.28% to -$829000.0 in 2024.
  • Per Business Quant, the three most recent readings for SLS's Other Gross PP&E Adjustments are -$829000.0 (Q3 2024), -$756000.0 (Q2 2024), and -$1.5 million (Q1 2024).